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CObjectives: Studies have shown that preference-based measures of
health-related quality of life (utility measures) fail to provide inter-
changeable values, which raises concerns for the cross-study compa-
rability of cost-effectiveness estimates. This study offers generalizable
and condition-specific insight into why (rather than if) there are dis-
crepancies between two widely used measures, the EQ-5D and SF-6D.
Methods: Comparisons focused on practical considerations and the
respective descriptive and valuation components of the measures, ad-
dressing empirical and conceptual issues. More specifically, we ad-
dressed instrument-completion, item-completion, contextual framing
of questions, dimension-to-dimension correlations, floor and ceiling
effects, and construct validity. Data came from randomized controlled
trial participants with nonspecific neck pain (n  346). Results: The
escriptive classification systems do not permit respondents to de-
cribe their health state in the samemanner, due, primarily, to contex-
ual differences and the number of available response options. Specific O
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oi:10.1016/j.jval.2010.09.002o neck pain populations, “vitality” was a unique contributor to the
F-6D, although both measures identified the same significant linear
rends across theoretical constructs. Rates of instrument completion
ere significantly better for the EQ-5D over the course of the random-
zed controlled trial.Conclusions: The EQ-5D and SF-6Ddonot provide
nterchangeable utility estimates for patients with nonspecific neck
ain—a finding that is common to other clinical areas. However, this
esult, and the results from previous studies, should not be surprising
iven the extent of between-measure differences relating to the de-
criptive content of health dimensions across the twomeasures. Given
he consistent messages emerging from method comparison studies
or the EQ-5D and SF-6D, newand/or novel approaches are necessary to
rive this research area forward.
eywords: EQ-5D, health-related quality of life, SF-6D, utilitymeasures.
opyright © 2011, International Society for Pharmacoeconomics and
utcomes Research (ISPOR). Published by Elsevier Inc.Introduction
For economic evaluation within a cost-utility framework, the
primary measure of effect must provide a single index value
that reflects respondents’ preferences for different health
states. Preferences can be measured directly using preference-
elicitation techniques or indirectly captured through the use of
preference-based health-related quality of life (HRQoL) instru-
ments, also known as utility measures. The use of indirect ap-
proaches is increasingly popular due to the availability of pop-
ulation-based health state valuations for every response
permutation and the ease of administration. However, the
availability of several instruments raises concerns about the
cross-study comparability of cost-utility results when studies
have used different outcome measures [1,2].
Preference-based HRQoL measures have two constituent
parts; a descriptive system that defines respondents’ HRQoL as
one of a finite number of health states and a valuation system
that scores each health state as a single index score, usually
* Address correspondence to: David G.T. Whitehurst, PhD, Schoo
West 10th Avenue, 7th floor, Research Pavilion, Vancouver, BC V5Z
E-mail address: david.whitehurst@ubc.ca.
098-3015/$36.00 – see front matter Copyright © 2011, Internation
ublished by Elsevier Inc.based on community-derived preferences. Index scores are in-
terpreted on a zero to one scale, where zero is a health state
equivalent to death and one indicates full health. Across a broad
range of clinical conditions and community-based samples,
previous comparative research of various preference-based
measures has identified that important differences exist, irre-
spective of the study population, the magnitude of the differ-
ence between scores, and the instruments under investigation
[1–11]. For example, in the United Kingdom, the EQ-5D and
SF-6D are the most widely used indirect measures and compar-
ative studies have identified weak or moderate levels of agree-
ment across many patient populations, including hearing im-
pairment [4], osteoporosis [1], chronic obstructive pulmonary
disease [1], leg ulcers [1], low back pain [1,10], cardiovascular
conditions [8], and psychosomatic disorders [8]. In addition to
he consistent evidence regarding agreement between the
Q-5D and SF-6D, other well-documented problems include the
resence of floor (SF-6D) and ceiling (EQ-5D) effects [1–3,6,8].
Knowing that outcome measures provide different esti-
ates is an important finding because it questions the under-
opulation and Public Health, University of British Columbia, 828
, Canada.
ciety for Pharmacoeconomics and Outcomes Research (ISPOR).
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532 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 5 3 1 – 5 3 8lying rationale for generic preference-based measurement; that
is, their use as a standardized measure of health benefit, within
a cost-utility framework. Within clearly defined patient popu-
lations, there is also a need to inform an important debate about
the appropriate choice of instrument and provide guidance for
the design of future studies. In addition, there is a more general
need to understand the reasons for between-measure discrep-
ancies. This article provides a direct head-to-head comparison
of the EQ-5D and SF-6D for a sample of patients with nonspecific
neck pain. Our analysis addresses a number of empirical and
conceptual issues to provide generalizable and condition-spe-
cific insights into why (rather than if) there are discrepancies
between EQ-5D and SF-6D index scores; we explore differences
in the practical application, descriptive systems, and index
scores of the two instruments.
Methods
Data source
The dataset included 346 randomized controlled trial participants
aged 18 years or olderwith nonspecific neck pain [12]. The primary
outcome measure was neck pain disability measured using the
Northwick Park Neck Pain Questionnaire; a 0 to 100 scale, where
0  no neck pain or disability, 100  maximum neck pain and
disability [13]. Outcome data, including the EQ-5D and SF-12, were
collected at baseline (assessment clinic), 6 weeks, and 6 months
(postal questionnaires).
Preference-based measures: the EQ-5D and SF-6D
The EQ-5D is a five-dimension self-classification system cover-
ing mobility, self-care, usual activities, pain/discomfort, and
anxiety/depression [14]. Each dimension contains three re-
sponse options, providing 243 (35) distinct health states. Health
states for “unconscious” and “dead” have been added. The
UK scoring algorithm was the first large-scale EQ-5D valuation
study and is the most widely used [15,16]. Health state valua-
tions were elicited from a representative sample of 3395 mem-
bers of the UK adult population using time trade-off methodol-
ogy. The resultant algorithm provides utility scores from0.594
(lowest level on each dimension) to 1.000 (highest level on each
dimension). Negative values reflect that some health states are
considered to be worse than death.
The SF-6D can be derived from two widely used generic health
profilemeasures, the Short Form36 (SF-36) [17] and the Short Form
12 (SF-12) [18]. In this study, SF-6D scores were estimated from
SF-12 version 2 responses [19]. The SF-6D is comprised of six di-
mensions (physical functioning, role limitations [physical and
emotional], bodily pain, vitality, social functioning, and mental
health) constructed from seven items of the 12-item instrument,
each with between three and five levels of severity. This descrip-
tive system defines 7500 health states. Health state valuations
were elicited using standard gamblemethodology, based on a rep-
resentative sample of 611 members of the UK adult population.
The range of SF-6D (SF-12) index scores is 0.345 to 1.000. The SF-6D
items and the EQ-5D were replicated in line with the official UK
validated versions; the EQ-5D appeared immediately before the
SF-12 in all questionnaires.
Methods of analysis
Before exploring potential reasons for between-measure discrep-
ancies, the expected disagreement between EQ-5D and SF-6D
scores needed to be confirmed. Assessment of agreement was
based on Bland and Altman plots and the intraclass correlation
coefficient (ICC) [20,21]. For the quantification of absolute agree-
ment, a single measure ICC based on a two-waymixed analysis ofvariance model was calculated, where the two measures are
treated as a source of variability.
The assessment of practicality focused on instrument-comple-
tion and item-completion. A questionnaire response was defined
as “instrument-complete” if all dimensions were completed for
the EQ-5D and SF-6D, respectively. “Item-completion” related to
the individual dimensions of the two measures. Differences
between questionnaire responders with and without valid utility
estimates were explored.
There were three considerations in the exploration of the
respective descriptive systems; the contextual framing of items,
dimension-to-dimension correlations, and floor and ceiling ef-
fects. Several a priori assertions were made regarding paired
dimensions across the EQ-5D and SF-6D that were expected to
be the highest correlations. For the assessment of floor and
ceiling effects, responses that were classified as “full health” or
“worst possible health” on one measure were examined more
closely in terms of their distribution on the other measure. Floor
and ceiling effects for individual dimensions were also studied
to further explore sources of disagreement.
The index values of the EQ-5D and SF-6D were assessed using
boxplots, descriptive statistics, and empirical validity testing. Box-
plots display a five-number data summary on one chart, providing
an efficient graphical method of displaying the location and
spread of continuous variables [22]. Descriptive statistics (number,
mean, standard deviation [SD], 95% confidence interval [CI], me-
dian, interquartile range, and range) were reported for the EQ-5D,
the SF-6D, and the difference between scores (calculated as EQ-5D
minus SF-6D) for each time point and for the combined sample.
Within-subject differences in mean and median utility scores
were tested using the paired t test andWilcoxon Signed Rank Test,
respectively. Validity testing has beendescribed as the acid test for
preference-basedmeasures as it provides a rationale for assessing
whether such measures do reflect preferences as opposed to
whether they could reflect preferences [23]. Validity testing ex-
plored within this study focused on construct validity, a tech-
nique that assesses the ability of an instrument(s) to discrimi-
nate between study populations thought to differ on the basis of
a theoretically constructed hypothesis. Hypothetically con-
structed preference rules were devised for a purposive selection
of generic and neck pain-specific outcome measures to explore
issues deemed to be important to utilitymeasures and reflective
of the opportunities within the dataset.
Three neck pain-related constructs were explored, relating to
severity (mild, moderate, and severe categories were defined from
a zero to 10 numerical rating scale for neck pain intensity [24]),
self-reported change (much better, better, same, worse, or much
worse) and tertile-defined groups for the Northwick Park Neck
Pain Questionnaire. Generic constructs focused on self-reported
health status (excellent, very good, good, fair, or poor), tertile-
defined groups for the EuroQol visual analogue scale (where 100
best imaginable health state and 0  worst imaginable health
tate) [14] and time off work for respondents currently in paid
mployment (yes or no). Tertile values split the dataset into three
qual-sized categories; the lower (upper) category reflects the low-
st (highest) third of valid responses. Analysis of the theoretical
onstructs consisted of computation of category-specific mean
cores and appropriate statistical tests (t tests and analysis of vari-
nce [ANOVA]) to explore the significance of linear trends. Due to
he different scoring ranges of the EQ-5D and SF-6D, the interpre-
ation of mean values reported within theoretically constructed
ategories was also assessed.
Results
The 346 trial participants provided a maximum number of 1038
(3 346) paired EQ-5D and SF-6D responses over the course of the
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533V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 5 3 1 – 5 3 8study, which formed the combined dataset. In total, 907 (87%) and
859 (83%) values were observed for the EQ-5D and SF-6D, respec-
tively (see Table 1).
Agreement
For the three distinct time points and the combined sample, ICC
values ranged between 0.518 (95% CI 0.43–0.59) at 6 weeks to 0.550
(95% CI 0.46–0.63) at 6 months. The Bland and Altman plot for the
combined dataset is presented in Figure 1. The width of the 95%
limits of agreement was 0.764, which is an estimate of the ex-
pected level of variation between future EQ-5D and SF-6D obser-
vations. At the lower end of the utility scale, 8% of paired observa-
tionswere below the lower limit, with less than 1% of observations
above the upper limit. Consistent results were observed across all
time point-specific analyses (baseline, 6 weeks, and 6 months).
Practicality and assessment of the descriptive systems
At each time point, instrument-completion rates were greater for
the EQ-5D than the SF-6D, ranging froma 2%difference at baseline
(100% and 98%), to a 7% difference at 6 months (78% and 71%) (see
Table 1). A significantly greater proportion of the sample provided
valid EQ-5D responses across all three time points (EQ-5D  74%,
SF-6D  64%; McNemar test, P  0.001).
Item-completion rates were consistent for EQ-5D dimensions
(100% at baseline, 85% at 6 weeks, and 79% at 6 months). With
he exception of the SF-6D “role limitations” dimension, which had
9%and 72%completion at 6weeks and 6months, respectively, sim-
Table 1 – Descriptive statistics of observed EQ-5D scores, S
(maximum n = 346)*.
EQ-5D
Baseline
n (%) 345 (10
Mean (SD) 0.662 (0.2
95% Confidence interval 0.636 to 0
Median 0.730
Interquartile range 0.690 to 0
Range 0.240 to 1
6 weeks
n (%) 291 (84
Mean (SD) 0.709 (0.2
95% Confidence interval 0.682 to 0
Median 0.760
Interquartile range 0.690 to 0
Range 0.240 to 1
6 months
n (%) 271 (78
Mean (SD) 0.694 (0.2
95% Confidence interval 0.661 to 0
Median 0.760
Interquartile range 0.660 to 0
Range 0.180 to 1
Combined sample (maximum n  1038)
n (%) 907 (87
Mean (SD) 0.686 (0.2
95% Confidence interval 0.670 to 0
Median 0.760
Interquartile range 0.690 to 0
Range 0.240 to 1
SD, standard deviation.
* Difference equals EQ-5D minus SF-6D for the respective sample of
† The minimum and maximum values are the smallest and largest
using the Wilcoxon Signed Rank Test.lar item-completion rates were observed for the SF-6D dimensions. ecross all time points, therewere 54 instanceswhere the EQ-5Dwas
he only index score that could be generated; of these observations,
4 (81%)weredue tonon-response to the “physical” itemof theSF-6D
ole limitations dimension. Respondents with missing data on this
tem were more likely to be older (t test, P  0.002) and not in paid
mployment at the time of recruitment (chi-square test, P  0.033)
ompared to respondents providing complete EQ-5DandSF-6Ddata.
Examination of the wording used in the EQ-5D and SF-6D iden-
ified two key differences that exist irrespective of the clinical con-
ext (i.e., between-measure differences that are generalizable be-
ond neck pain). Firstly, EQ-5D response options focus exclusively
n severity, whereas SF-6D items require respondents to consider
he duration of impairment or the extent to which specific health
imensions affect their lives. These two approaches provide re-
pondents with two contextually different sets of dimensions from
hich to describe their health state, such that poor agreement be-
ween paired dimension-specific responses that would be expected
o have a strong relationship with each other would not infer in-
onsistent or contradictory responses. For example, within the
ombined dataset, of 624 level-2 responses on the EQ-5D pain/
iscomfort dimension, 70 (11%) observations had a matched re-
ponse at level 1 on the SF-6D pain dimension, whereas 118 (19%)
bservations had a matched response at level 4 or level 5. The
econd contextual difference relates to the length of time respon-
ents are asked to consider when completing the questionnaires.
he EQ-5D asks respondents to indicate the response option that
est describes their health state on the day of completion,whereas
he acute version of the SF-12 asks respondents to consider their
scores, and the difference between paired observations
SF-6D Difference†
338 (98) 7 (2)
0.698 (0.14) 0.035 (0.19)
0.683 to 0.713 0.056 to 0.014
0.694 0.007
0.593 to 0.800 0.115 to 0.093
0.345 to 1.000 0.000 to 0.659
271 (78) 20 (6)
0.732 (0.14) 0.019 (0.18)
0.716 to 0.749 0.040 to 0.003
0.723 0.007
0.623 to 0.859 0.100 to 0.087
0.378 to 1.000 0.000 to 0.640
247 (71) 24 (7)
0.722 (0.15) 0.030 (0.21)
0.703 to 0.740 0.056 to 0.003
0.723 0.004
0.606 to 0.859 0.096 to 0.118
0.378 to 1.000 0.000 to 0.695
859 (83) 48 (5)
0.716 (0.14) 0.028 (0.20)
0.706 to 0.725 0.041 to 0.015
0.720 0.007
0.611 to 0.859 0.103 to 0.100
0.345 to 1.000 0.000 to 0.695
hed paired observations.
lute values. There were no significant differences in median valuesF-6D
0)
4)
.687
.800
.000
)
4)
.736
.800
.000
)
7)
.727
.800
.000
)
5)
.703
.800
.000
matc
absoxperiences during the past week.
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534 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 5 3 1 – 5 3 8Table 2 presents the coefficient matrix for the combined
dataset. Of the eight paired dimensions that were expected to be
among the highest correlations, four had a correlation coefficient
greater than 0.500 and were among the highest five coefficients.
The unexpected correlation within the highest five values was be-
tween pain (SF-6D) and usual activities (EQ-5D). The four lowest cor-
relations all involved the mental health dimension of the SF-6D.
These results suggest there is evidence for convergent (discriminant)
validitybetweensimilar (dissimilar)dimensions, in linewithhypoth-
esized expectancies.
Within the combined sample, there were 107 (13%) paired ob-
servations with an EQ-5D classification at full health. For this
subsample of responses, the mean SF-6D score was 0.852 0.09.
ull health was reported on the SF-6D on 7 (less than 1%) occa-
ions; matched EQ-5D responses were full health (three times)
r a value of 0.800 (four times). No respondents reported the low-
st possible health state on the EQ-5D. The lowest health state for
he SF-6D was reported twice; corresponding EQ-5D index scores
ere both below the minimum value on the SF-6D (0.080 and
.090). For the 107 respondents reporting full health on the EQ-5D,
ach SF-6D dimension indicated some level of impairment in at
Fig. 1 – Bland and Altman plot showing the mean difference
associated 95% limits of agreement (dashed lines), for the co
difference between scores and the average of the scores for
Table 2 – Spearman’s correlation matrix for EQ-5D and SF-
respondents (n = 853)*.
SF-6D
EQ-5D Mobility Self-care
Physical functioning 0.488 0.391
Role limitations 0.322 0.256
Pain 0.467 0.362
Vitality 0.340 0.267
Mental health 0.194 0.171
Social functioning 0.412 0.330
* The five most correlated dimensions are in bold. The underlined coof quality of life.east 10% of matched responses; role limitations, pain, vitality,
ndmental health reported impairment in at least 25%ofmatched
esponses. For the vitality dimension, only 4% of respondents re-
orting “full health” according to the EQ-5D reported the top-level
esponse option.
EQ-5D item-responses in the top category of the respective di-
ensions ranged from 17% (pain/discomfort) to 89% (self-care),
ompared to a range of 3% (vitality) to 53% (social functioning) for
he SF-6D. The lowest EQ-5D response option for the mobility di-
ension (“I am confined to bed”) was reported once, while there
ere no level-3 responses for the self-care dimension (“I am un-
ble to wash or dressmyself”). This contrasts to the physical func-
ioning and role limitations dimensions of the SF-6D, where the
owest categories were reported in 17% and 41% of responses, re-
pectively.
Assessment of EQ-5D and SF-6D index scores
A boxplot of EQ-5D and SF-6D index scores is shown in Figure 2,
which identifies EQ-5D outliers that correspond to health state
values below the minimum value for the SF-6D and highlights the
een paired EQ-5D and SF-6D scores (solid line) and
ned data sample (n = 853). The markers represent the
paired observation.
imensions. Data relate to the combined data sample of
Usual
activities
Pain/
discomfort
Anxiety/
depression
0.619 0.483 0.233
0.442 0.353 0.511
0.612 0.590 0.318
0.323 0.279 0.300
0.221 0.231 0.596
0.443 0.416 0.432
ions were identified a priori as purporting to capture similar aspectsbetw
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535V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 5 3 1 – 5 3 8skewed nature of EQ-5D index scores. Descriptive statistics across
each data collection stage are presented in Table 1. The mean
index score for the EQ-5D was consistently lower than for the
SF-6D. The differences between paired index scores were statisti-
cally significant at baseline and for the combined sample (paired t
test, P 0.001). The reverse was true for median values, where the
Q-5D provided higher median scores at each time point com-
ared to the SF-6D, although no significant differences were ob-
erved.
Mean scores for the theoretical constructs concerning EQ-5D
nd SF-6D index scores and change scores at 6 months are pre-
ented in Table 3. Statistically significant linear trends were iden-
ified for all analyses that focused on index scores (consistent
cross the different time points and the combined sample) and
-month change scores (P  0.001). The results of the construct
nalyses, which were in line with the hypothesized constructs,
ere indistinguishable for the EQ-5D and SF-6D measures. Mean
F-6D scores associated with the lowest response categories on
he pain severity and self-reported general health status variables
ere 0.560 and 0.496, respectively. Mean EQ-5D scores for the
ame response categories were 0.359 (severe pain) and 0.190
“poor” self-reported health); these are scores that are toward and
eyond the minimum value attainable on the SF-6D and still
omeway short of the minimum EQ-5D score.
Discussion
Preference-basedmeasures of health-related quality of life are in-
Fig. 2 – Boxplot for observed utility scores derived from the E
the median (thick line), the interquartile range (box), values
and outliers (crosses).creasingly being used in health services research. The analysisreported in this paper investigated the comparative performance
of the twomost widely used UK-specific measures, the EQ-5D and
the SF-6D, within a sample of patients with nonspecific neck pain.
Previous studies have sought to determine the level of agreement
between these two measures [1–11]; our objective was to provide
generalizable and neck pain-specific insights as to why the EQ-5D
and SF-6D do not provide comparable utility estimates. As a nec-
essary first step, we demonstrated the expected disagreement be-
tween EQ-5D and SF-6D scores; limits of agreement within the
Bland and Altman plot (Fig. 1) demonstrated a wide expected level
of variation, despite ICC values indicating “fair” agreement [21].
Themagnitude of disagreement wasmore severe at the lower end
of the zero to one utility scale.
Neck-pain-specific insight
The EQ-5D consistently provided a higher proportion of valid util-
ity estimates compared to the SF-6D. The statistically significant
difference in instrument-completion over the 12-month period is
an important practical consideration because utility measures are
primarily used as longitudinal measures to calculate quality-
adjusted life years. Previous research has suggested that the SF-36
and SF-12 have a number of problematic questions that may ad-
versely affect response rates, including the role limitation items.
Proposed reasons for non-response include poor linkage be-
tweenquestions and response options [25,26], and the reference to
“work’” within some items [27]. Within our data, respondents who
had failed to complete the physical role limitations question were
more likely to be older and not currently in paid employment,
D and SF-6D at each data collection stage. The plots depict
in 1.5 box-lengths from either end of the box (whiskers)Q-5
withwhich concurswith the findings of Barton et al. [7]. However, these
a
j
e
d
t
s
c
t
n
s
s
i
m
ent.
536 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 5 3 1 – 5 3 8reasons do not provide an explanation why the item-completion
rate for the physical role limitations itemwas the only anomalous
result (e.g., the emotional item of the role limitations dimensions
also refers to work).
Differences in the descriptive systems were seen in relation
to the SF-6D vitality dimension and ceiling effects for the EQ-5D.
The SF-6D vitality dimension had a relatively low correlation
with each EQ-5D dimension, and the distribution of responses
was markedly different to any other across both measures. Pre-
vious research has indicated that vitality [28], social functioning
[28], and role limitations [29] are SF-6D dimensions that are not
dequately captured by the EQ-5D, although the techniques and
udgments used to reach such conclusions are varied. The pres-
nce of ceiling effects for EQ-5D index scores and individual
imensions indicate that response options are missing toward
he upper end of the scale, meaning that patients in mild health
tates cannot be distinguished from each other. More specifi-
ally, these findings suggest that the three-level response op-
ion on the EQ-5D does not allow respondents to indicate a
on-negligible degree of impairment when in mild health
tates.
It was not possible to select a better measure based on the
tatistical significance of linear trends explored across theoret-
cal constructs. However, such analysis takes no account of the
Table 3 – Descriptive statistics for the pain-related and gen
the combined sample unless stated otherwise*.
E
n (%)
Neck pain severity
Mild 509 (56)
Moderate 310 (34)
Severe 86 (10)
Self-reported assessment of change†
Much better 82 (30)
Better 83 (31)
Same 82 (30)
Worse 20 (7)
Much worse 3 (1)
Northwick Park NPQ‡
Group 1 (lowest scores) 297 (33)
Group 2 298 (33)
Group 3 (highest scores) 298 (33)
Self-reported health status
Excellent 19 (2)
Very good 193 (21)
Good 436 (48)
Fair 213 (24)
Poor 43 (5)
EuroQol visual analogue scale§
Group 1 (lowest scores) 301 (33)
Group 2 301 (33)
Group 3 (highest scores) 302 (33)
Employed respondents
Reported time off work 92 (18)
Did not report time off work 421 (82)
SD, standard deviation.
* All tests for linear trend were statistically significant (P  0.001). Ita
test) could not be assumed.
† Values are mean 6-month change scores (6-month score minus ba
‡ Higher scores reflect a greater degree of disability.
§ Higher scores reflect a greater self-reported general health status.
 Sample consists of respondents in full-time or part-time employmean values in absolute terms. Mean SF-6D scores associatedwith the lowest response categories on the pain severity vari-
able and self-reported general health status may not be consid-
ered low despite their association with poor or severe health
states; the same was not true of the EQ-5D, which suggests that
the EQ-5D may be better suited to capture the magnitude of
severity for poor health states. A similar finding has been ob-
served for patients with knee pain, where Barton and colleagues
report mean EQ-5D and SF-6D scores of 0.366 and 0.561, respec-
tively, for patients with moderate to extreme knee pain [30].
However, whether the lower scores observed for the EQ-5D
compared to the SF-6D for “poor” health states reflects societal
and/or patient preferences is an empirical question that is not
addressed in this analysis. The narrow scoring range of the
SF-6D creates a problem because of the normative application of
preference-based utility measures. The SF-6D will overestimate
quality-adjusted life year estimates for participants in severe
health states. The consequence is that utility increments (or,
more specifically, quality-adjusted life year increments) for
health care interventions aimed at treating chronic patients
may be smaller when using the SF-6D compared to the EQ-5D.
Generalizable insight into between-measure discrepancies
In the analysis and consideration of whether the EQ-5D or the
hypothesized constructs. Data relate to index scores for
SF-6D
Mean (SD) n (%) Mean (SD)
0.778 (0.18) 486 (57) 0.773 (0.12)
0.627 (0.24) 290 (34) 0.664 (0.12)
0.359 (0.32) 82 (10) 0.560 (0.11)
0.098 (0.15) 73 (30) 0.065 (0.12)
0.013 (0.27) 74 (31) 0.028 (0.13)
0.004 (0.29) 72 (30) 0.015 (0.10)
0.152 (0.31) 19 (8) 0.052 (0.10)
0.497 (0.26) 3 (1) 0.090 (0.15)
0.826 (0.16) 283 (33) 0.801 (0.11)
0.727 (0.13) 283 (33) 0.737 (0.12)
0.509 (0.30) 284 (33) 0.610 (0.12)
0.808 (0.16) 18 (2) 0.856 (0.11)
0.812 (0.15) 188 (22) 0.808 (0.11)
0.728 (0.20) 415 (48) 0.733 (0.12)
0.579 (0.26) 198 (23) 0.622 (0.10)
0.190 (0.29) 40 (5) 0.496 (0.09)
0.516 (0.30) 284 (33) 0.616 (0.12)
0.740 (0.17) 285 (33) 0.727 (0.12)
0.804 (0.16) 285 (33) 0.805 (0.11)
0.670 (0.23) 89 (18) 0.682 (0.14)
0.770 (0.17) 404 (82) 0.766 (0.12)
enote analyses where equality of variances across groups (Levene’s
score).eric
Q-5D
lics d
selineSF-6D is the appropriate preference-based instrument for the
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537V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 5 3 1 – 5 3 8assessment of nonspecific neck pain interventions, important
normative questions emerged in relation to the contextual
framing of EQ-5D and SF-6D items. Firstly, an examination of
question formats led to the supposition that so-called “similar
dimensions” across the twomeasures should not be expected to
provide similar response patterns. This difference, coupled
with the ceiling effects observed for the EQ-5D and the apparent
unique contribution of the SF-6D vitality dimension, shows that
the descriptive classification systems differ to such an extent
that contemporaneous EQ-5D and SF-6D valuations attached to
health states should not be expected to provide similar esti-
mates, irrespective of the preference elicitation technique used
in the respective valuation studies. Secondly, should the re-
sponse options for a particular dimension of health be based on
the level of severity currently experienced by the respondent?
The EQ-5D adopts this approach, with the response options
broadly described as no problems, some problems, and extreme
problems across the five dimensions. Alternatively, the SF-6D
asks respondents to consider aspects such as the duration of
impairment for a specified time period or the extent to which a
particular dimension interferes with regular daily activities.
A similar issue ariseswith regard to the period of recall respon-
dents are asked to consider when completing the instruments.
The EQ-5D asks respondents to indicate the response option that
best describes their health state on the day of completion,whereas
the SF-6D asks respondents to consider their experiences during
the past week (if using the acute version) or the past 4 weeks (if
using the standard version). It was not possible to assess whether
different recall periods resulted in systematically different valua-
tions of health utility within our dataset. However, Bansback et al.
[31] reported that an instrument with a 7-day recall period will
rovide lower utility values for recently resolved adverse events
hen compared to an instrument with a 1-day recall period, al-
hough those authors accept that study limitations means that
urther research would be necessary to validate their results. The
K standard gamble-derived scoring algorithms for the SF-6D
ake no allowance for the different recall periods of the 4-week
nd 1-week versions of the SF-12 and SF-36, providing the implicit
ssumption that different lengths of recall do not result in system-
tically different descriptions and/or valuations of health status
19,32].
These normative questions have received little attention in the
literature and, therefore, it is not possible to state which is the
better contextual basis for framing questions or the most appro-
priate period of recall. However, it is important to be aware of
between-measure discrepancies attributable to these characteris-
tics to informmethodological debate and instrument selection for
future studies and assist in the development of new measures or
the amendment of existing instruments.
Strengths and limitations
The strengths of our analysis lie in the switch of focus to assess
why different utility measures provide incomparable estimates,
using a comprehensive range of techniques to evaluate issues of
practicality and the respective descriptive and valuation systems.
A particular focus of the empirical analysis was to ensure that the
adopted methods were able to address the specific concerns of
preference-basedmeasures. For example, somemethods of agree-
ment analysis used in different settings are not appropriate for
method comparison studies of preference-basedmeasures. An ex-
ample of this is the determination of regression-based limits of
agreement for Bland and Altman plots to account for systematic
relationships between the difference between scores and themag-
nitude of scores [33].
Although some preference-based method comparison studies
have used these techniques [10], it is nonsensical to account for this
relationship when quantifying agreement between two alternativeutility measures. Knowledge of the level of agreement between util-
ity measures following a regression-based adjustment is of no value
because themeasures are only used in their observed absolute form.
For this reason, thequantificationof agreement in this study focused
on the utility values in their observed form.
Although this analysis has identified a number of insights into
between-measure discrepancies, there are limitations. Firstly, the
application of parametric statistical methods requires data to be
approximately normally distributed. Typically, EQ-5D scores are
negatively skewed. However, it has been demonstrated that para-
metric techniques are robust to violation of the Normality as-
sumption common to many quality of life outcomes that have
discrete, bounded and skewed distributions [34].
A second limitation relates to the importance of reproducibility
and responsiveness in method comparison studies [33,35]. The
classic definition of responsiveness asserts that health status
questionnaires should have the ability to detect clinically impor-
tant differences over time [36]; a less stringent definition relates to
longitudinal validity; that is, the assessment of predefined hy-
potheses regarding change scores [35]. Adopting the latter defini-
tion, our analysis of theoretical constructs using EQ-5D and SF-6D
change scores inferred that the twomeasures were indistinguish-
able in their responsiveness to changes in self-reported neck pain
status. A third potential limitation concerns the combination of
repeated observations to form a single sample because within-
subject observations are not independent [37]. The importance of
ignoring the non-independence of observations will depend on
the analysis being performed and such methods have been
adopted in previous method comparison studies [1]. In this study,
esults relating to the combined sample dataset were reported
henfindings and interpretationwere analogous to the respective
ime point-specific analyses.
Conclusions
Our analysis provides a novel examination of the nature of be-
tween-measure discrepancies, while adding to the existing litera-
ture regarding the comparability of EQ-5D and SF-6D utility esti-
mates. Irrespective of the oft-cited dissimilarity of scoring ranges
across the two measures, differences across the respective de-
scriptive classification systems provide generalizable findings rel-
evant to all clinical samples (in terms of the context of question
formats and the recall period ofmeasurement) and results specific
to nonspecific neck pain samples (e.g., the unique contribution of
vitality to the SF-6D instrument), which demonstrate why utility
estimates should not be expected to be comparable.
In their current formats, the wider scoring range and better
completion rates associatedwith the EQ-5D, coupledwith the lack
of clear advantages relating to the SF-6D, provide sufficient justi-
fication for it to remain the industry standard. In addition, recent
developments with regard to a five-level response-option version
of the EQ-5D should improve the descriptive richness of the Euro-
Qol instrument [38].
Further research, adopting new analytical ideas, is needed to
understand between-measure discrepancies and the consequen-
tial implications for cost-effectiveness estimation. Early findings
suggest that the sensitivity of EQ-5D-derived and SF-6D-derived
cost-effectiveness estimates is expected to differ between patient
groups and interventions; consistent, systematic observations, if
they exist, are yet to be identified [39,40].
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